Healthcare


 Race Oncology Releases Its December Quarter Result Update

Race Oncology Releases Its December Quarter Result Update

January 29, 2019 08:30 AM AEDT| By Team Kalkine Media

On 25 January 2019, Race Oncology Ltd (ASX: RAC), a pharmaceutical company, has announced its Consolidated Quarterly statement of cash flows. As at 31 December 2018, the Company?s cash balance was AUD 2,079,000, representing a decrease from the cash...

 OCA Announces Decent 1HY2019 Results

OCA Announces Decent 1HY2019 Results

January 28, 2019 06:07 PM AEDT| By Team Kalkine Media

Oceania Healthcare Limited (ASX: OCA) announces its half-yearly results to the market (6 months to 30 November 2018). The underlying NPAT was 5.3% above 1HY2018 and there is 8.7% growth in continuing operations as compared to 1HY2018. OCA is a care f...

 Althea Group Announces Achievement Of 300 Patients: What Market Players Need To Know

Althea Group Announces Achievement Of 300 Patients: What Market Players Need To Know

January 25, 2019 09:30 PM AEDT| By Team Kalkine Media

Althea Group Holdings (ASX: AGH) had come forward and made an announcement about the patients which were prescribed its medicinal cannabis with the help of the press release. Althea Group Holdings happens to be the licensed producer as well as import...

 The Share Price Of Factor Therapeutics Remains Unaffected By The Retirement Of The Chief Executive Officer

The Share Price Of Factor Therapeutics Remains Unaffected By The Retirement Of The Chief Executive Officer

January 25, 2019 09:17 PM AEDT| By Team Kalkine Media

Biotechnology Company, Factor Therapeutics Limited (ASX: FTT) today made an announcement regarding a change in the Company's management. In the announcement, the company has informed that Dr. Rosalind Wilson has completed her tenure as Chief Executiv...

 Why ResMed's Stock Nosedived Today?

Why ResMed's Stock Nosedived Today?

January 25, 2019 06:51 PM AEDT| By Team Kalkine Media

On 25 January 2019, ResMed Inc. (NYSE: RMD, ASX: RMD) announced its December quarter financial and business results. ResMed is a leading player under Australia?s health care sector, engaged in offering innovative cloud-connected medical devices trans...

 AusCann Group Announced Research & Development Facility Acquisition

AusCann Group Announced Research & Development Facility Acquisition

January 25, 2019 06:00 PM AEDT| By Team Kalkine Media

AusCann Group Holdings Limited (ASX: AC8) had made an announcement of the acquisition of Research and Development Facility with the help of press release. As per the press release dated January 25, 2019, the company stated that they have wrapped up t...

 Alcidion Group Announces Key Changes In Its Board And Senior Management

Alcidion Group Announces Key Changes In Its Board And Senior Management

January 25, 2019 04:14 PM AEDT| By Team Kalkine Media

On 25 January 2019, Alcidion Group Limited (ASX: ALC) has announced changes in its Board and senior management, as the company begins its next stage of growth following the successful integration of MKM Health and Patientrack into the Alcidion Group...

 Botanix Pharmaceuticals Moves Up On ASX On Completion of Investigator’s Meeting for BTX 1204 Phase 2 Atopic Dermatitis Clinical Study

Botanix Pharmaceuticals Moves Up On ASX On Completion of Investigator’s Meeting for BTX 1204 Phase 2 Atopic Dermatitis Clinical Study

January 25, 2019 02:44 PM AEDT| By Team Kalkine Media

On 25 January 2019, biopharmaceutical dermatology company, Botanix Pharmaceuticals Limited (ASX: BOT) announced that it had completed its Investigator?s Meeting for the BTX 1204 Phase 2 atopic dermatitis clinical study with investigating dermatologis...

 50% Crash In The Price Of Creso Pharma In 1 Year

50% Crash In The Price Of Creso Pharma In 1 Year

January 25, 2019 02:08 PM AEDT| By Team Kalkine Media

Medical Cannabis Company, Creso Pharma Limited?s (ASX: CPH) shares have lost almost half their value in the last one year. Despite being a part of the booming cannabis industry, this pot stock?s share prices have declined by approximately 50 percent...

 EMvision Announced Positive Safety Observations From Healthy Human Trials

EMvision Announced Positive Safety Observations From Healthy Human Trials

January 24, 2019 07:20 PM AEDT| By Team Kalkine Media

Medical device company, EMvision Medical devices Ltd (ASX: EMV) made an announcement today (24 January 2019) in which the company disclosed positive safety observations from healthy human trials conducted at the University of Queensland. Following th...

 Why Did Proteomics International Plunge By Over 11% On ASX?

Why Did Proteomics International Plunge By Over 11% On ASX?

January 24, 2019 06:06 PM AEDT| By Team Kalkine Media

On 24 January 2019, a medical technology company, Proteomics International Laboratories Limited (ASX: PIQ), announced that it had withdrawn its exclusive licensing deal with medical diagnostics company, PrismHealthDx due to continuing rollout postpon...

 ImExHS Limited Signs New Distribution Agreement in Panama

ImExHS Limited Signs New Distribution Agreement in Panama

January 24, 2019 05:12 PM AEDT| By Team Kalkine Media

The company announces that it has recently signed a new non-exclusive distribution agreement, with a leading medical and security technology company in Panama known as ATX Panama SA (ATX). This agreement now offers a great opportunity to expand its p...

 Creso Pharma Limited Raised $3 Million In Institutional Placement

Creso Pharma Limited Raised $3 Million In Institutional Placement

January 24, 2019 02:09 PM AEDT| By Team Kalkine Media

Creso Pharma Limited (ASX: CPH) develops and commercializes innovative and high-quality cannabis product. The company made an announcement today (24 January 2019) stating that it has successfully raised $3 million in Institutional Placement. Earlier...

 The Share Price of RGS Zoomed Up By 6.061% Post The Appointment Of The New CEO

The Share Price of RGS Zoomed Up By 6.061% Post The Appointment Of The New CEO

January 24, 2019 01:39 PM AEDT| By Team Kalkine Media

Regeneus Limited (ASX: RGS), a healthcare company which deals with regenerative medicine announced the appointment of Mr. Leo Lee as their new Chief Executive officer and member of the board with immediate effect. He will be replacing the outgoing CE...

 IHL Enters Exclusive Supply Agreement with Corporate Dentist 1300 Smiles

IHL Enters Exclusive Supply Agreement with Corporate Dentist 1300 Smiles

January 23, 2019 11:50 PM AEDT| By Team Kalkine Media

On 23 January 2019, Impression Healthcare Limited (ASX: IHL) signed an exclusive supply agreement with 1300 SMILES Limited (ASX: ONT), a leading dental group with a strong presence in Queensland. As per the agreement, from February, all the custom-f...

 AdAlta Releases Its December Quarter Business Report

AdAlta Releases Its December Quarter Business Report

January 23, 2019 01:35 PM AEDT| By Team Kalkine Media

On 22 January 2019, AdAlta Limited (ASX:1AD) has released a manufacturing update for AD-214. Based on current timelines, manufacturing remains on track which will move AdAlta?s lead program for the treatment of Idiopathic Pulmonary Fibrosis (IPF) int...

 Race Oncology On-Boards Professor Borje Andersson To Support Bisantrene Initiatives

Race Oncology On-Boards Professor Borje Andersson To Support Bisantrene Initiatives

January 22, 2019 09:04 PM AEDT| By Team Kalkine Media

On 22 January 2019, Race Oncology Limited (ASX: RAC) announced that it had signed a consulting agreement with Professor Borje Andersson from the M.D. Anderson Cancer Research Centre in Texas, for an initial period of 12 months. Race Oncology is an A...

 Creso Pharma Limited On Its Latest Agreement And Investment Update

Creso Pharma Limited On Its Latest Agreement And Investment Update

January 22, 2019 08:00 PM AEDT| By Team Kalkine Media

Creso falls under pharmaceuticals, biotechnology & life sciences industry group and is engaged into registering, developing, and commercialising pharmaceutical-grade cannabis and hemp-based products. On its agreement with TerrAscend: To meet co...

 Sienna Continues its Global Expansion in IVD Market with Distributor for the Republic of Korea

Sienna Continues its Global Expansion in IVD Market with Distributor for the Republic of Korea

January 22, 2019 07:15 PM AEDT| By Team Kalkine Media

On 22 January 2019, Sienna Cancer Diagnostics Limited (ASX: SDX) has announced to continue its global expansion on the back of signing a new distributor for South Korea. Mirax Corporation is the second Asian distributor for Sienna which has a ready...

 MGC Accomplishes Major Regulatory Milestones For Pharma Business

MGC Accomplishes Major Regulatory Milestones For Pharma Business

January 22, 2019 05:31 PM AEDT| By Team Kalkine Media

MGC Pharmaceuticals Ltd (ASX: MXC) has announced several important milestones in Pharma Business for the European and Australian manufacturing and research operations in the last few weeks, that materially advances the Company towards commercializati...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.